Moreover, it is known that metabolic disorders characterized by hyperglycemia, dyslipidemia, hypertension, chronic inflammation, or insulin resistance, especially in diabetes (regardless of type) and obesity, often show higher S100B levels than in the control group. This evidence concerns the gene S100B and obesity disorder.